AbbVie's (ABBV) Allergan Submits NDA to FDA for AGN-190584 to Treat Presbyopia
Go back to AbbVie's (ABBV) Allergan Submits NDA to FDA for AGN-190584 to Treat PresbyopiaAbbVie (NYSE: ABBV) | Delayed: 166.41 +1.75 (1.06%) | |||||
---|---|---|---|---|---|---|
Previous Close | $164.66 | 52 Week High | $68.12 | |||
Open | $165.02 | 52 Week Low | $50.71 | |||
Day High | $166.60 | P/E | 36.10 | |||
Day Low | $163.25 | EPS | $4.61 | |||
Volume | 5,532,362 |